Purchase Order HHSN271201600028A
Award Date 8/19/16
Potential Completion Date 10/30/16
Potential Value $342K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, identified as HHSN271201500078C, was made by the National Institute on Drug Abuse, a civilian agency, to Lavision Biotec GMBH, a for-profit organization and manufacturer of goods. The contract is a definitive, firm fixed-price contract with a ceiling value of $319,885.49 and an ultimate completion date of February 10, 2016. The contract was awarded on August 5, 2015 and does not have a set-aside designation. The contract appears to be for POTS 15-3530, as described...
- This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- <p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
- The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $142,160 firm fixed price purchase order contract to Nordicneurolab, Inc., a for-profit medical device manufacturer, for the provision of visual systems. The contract has an ultimate completion date of August 11, 2029. This award did not involve any set-aside designations. Nordicneurolab has previously received several other prime contract awards from various federal agencies for medical equipment and related...
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,600.00 firm fixed-price purchase order contract to Neurostatus-Uhb AG, a foreign-owned for-profit organization, for a NeuroStatus e-test license and EDSS training. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025. The contract was not set aside for any specific business designation.</p>
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. government, awarded a $89,710.00 firm fixed-price purchase order contract to Mad City Labs, Inc. to procure a Micromirror Total Internal Reflection Fluorescence (TIRF) Microscope. The contract was awarded on June 5, 2020 with a completion date of September 25, 2025. The original solicitation was posted on May 8, 2020 and was not set aside for any specific business category. The microscope system will support...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $130,350 firm fixed-price purchase order to Nanjing Transcend Vivoscope Biotechnology Co., LTD for the development and delivery of a miniature two-photon microscope system designed for neurological research in mice. The system, which weighs approximately 2.5 grams and measures 20 x 10 x 30 millimeters, is engineered to record calcium-indicator activities of individual neurons in...
- The National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a $50,507.70 firm fixed price delivery order contract to Leica Microsystems Inc., a manufacturer of microscopes and imaging equipment. The contract is for 3D data visualization and lightning process analysis of high-resolution 3D dynamics using a Leica Stellaris 8 STED with lightning system. The contract does not have a set-aside designation and is being issued under Leica's Multiple Award Schedule (MAS) contract....